0001214659-13-002572.txt : 20130509 0001214659-13-002572.hdr.sgml : 20130509 20130508182645 ACCESSION NUMBER: 0001214659-13-002572 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130509 DATE AS OF CHANGE: 20130508 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SINOVAC BIOTECH LTD CENTRAL INDEX KEY: 0001084201 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: B9 FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-79318 FILM NUMBER: 13825969 BUSINESS ADDRESS: STREET 1: 39 SHANGDI XI ROAD STREET 2: HAIDIAN DISTRICT CITY: BEIJING STATE: F4 ZIP: 100085 BUSINESS PHONE: 86-10-82890088 MAIL ADDRESS: STREET 1: 39 SHANGDI XI ROAD STREET 2: HAIDIAN DISTRICT CITY: BEIJING STATE: F4 ZIP: 100085 FORMER COMPANY: FORMER CONFORMED NAME: NET FORCE SYSTEMS INC DATE OF NAME CHANGE: 19991110 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: 1Globe Capital LLC CENTRAL INDEX KEY: 0001562189 IRS NUMBER: 800841812 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 333 PROVIDENCE HIGHWAY CITY: BOSTON STATE: MA ZIP: 02062 BUSINESS PHONE: 5148398866 MAIL ADDRESS: STREET 1: 333 PROVIDENCE HIGHWAY CITY: BOSTON STATE: MA ZIP: 02062 SC 13G 1 c58131sc13g.htm c58131sc13g.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
    
SCHEDULE 13G
  
Under the Securities Exchange Act of 1934
(Amendment No.    )*
 
SINOVAC BIOTECH LTD.
(Name of Issuer)
 
Common Stock
(Title of Class of Securities)
      
 
P8696W104
 
 
(CUSIP Number)
 
 
April 29, 2013
(Date of Event Which Requires Filing of This Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
  o
Rule 13d-1(b)
 
 
 
  x
Rule 13d-1(c)
 
 
 
  o
Rule 13d-1(d)
 
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).



 
Page 1 of 6 pages

 
 
CUSIP No.  P8696W104
1
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
1Globe Capital LLC 80-0841812
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
 
 
(a) o
(b) o
3
SEC USE ONLY
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware, USA
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH REPORTING
PERSON WITH:
5
SOLE VOTING POWER
 
3,385,776
6
SHARED VOTING POWER
 
 
7
SOLE DISPOSITIVE POWER
 
3,385,776
8
SHARED DISPOSITIVE POWER
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
3,385,776
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)
 
o
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
6.19%
12
TYPE OF REPORTING PERSON (see instructions)
 
PN
 
 
 
Page 2 of 6 pages

 
Item 1(a).
Name of Issuer:
 
 
 
Sinovac Biotech Ltd.
 
 
Item 1(b).
Address of Issuer’s Principal Executive Offices:
 
 
 
39 Shangdi Xi Road, Haidian District, Beijing, 100085, China,
 
 
Item 2(a).
Name of Person Filing:
 
 
 
1Globe Capital LLC
 
 
Item 2(b).
Address of Principal Business Office or, if none, Residence:
 
 
 
245 First Street
Riverview II
18th Floor
Cambridge, MA 02142dress, City, State, ZIP
 
 
Item 2(c).
Citizenship:
 
 
 
USA
 
 
Item 2(d).
Title of Class of Securities:
 
 
 
Common Stock
 
 
Item 2(e).
CUSIP Number:  P8696W104
 
Page 3 of 6 pages

 

Item 3.
If this Statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
 
(a)
o
Broker or dealer registered under Section 15 of the Act;
 
(b)
o
Bank as defined in Section 3(a)(6) of the Act;
 
(c)
o
Insurance company as defined in Section 3(a)(19) of the Act;
 
(d)
o
Investment company registered under Section 8 of the Investment Company Act of 1940;
 
(e)
o
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
 
(f)
o
An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
 
(g)
o
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
 
(h)
o
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
 
(i)
o
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
 
(j)
o
A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
 
(k)
o
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

Item 4.
Ownership.
 
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 
(a)
Amount Beneficially Owned:
3,385,776
 
(b)
Percent of Class:
6.19%
 
(c)
Number of shares as to which such person has:
 
 
(i)
sole power to vote or to direct the vote:
3,385,776
 
 
(ii)
shared power to vote or to direct the vote:
     
 
 
(iii)
sole power to dispose or to direct the disposition of:
3,385,776
 
 
(iv)
shared power to dispose or to direct the disposition of:
     
  
 
Page 4 of 6 pages

 

Item 5.
Ownership of Five Percent or Less of a Class.
 
 
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.
   
Item 6.
Ownership of More than Five Percent on Behalf of Another Person.
 
 
 
Not applicable.
 
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
 
 
 
Not applicable.
 
 
Item 8.
Identification and Classification of Members of the Group.
 
 
 
Not applicable.
 
 
Item 9.
Notice of Dissolution of Group.
 
 
 
Not applicable.
 
 
Item 10.
Certification.
 
 
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of and do not have the effect of changing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect for the time being.
 
 
Page 5 of 6 pages

 
SIGNATURE
  
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
 
May 8, 2013
 
 
Date
 
 
 
 
 
/s/ Jeff Li
 
 
Signature
 
 
 
 
 
Managing Director
 
 
Name/Title
 
 
 
 
 
 
Page 6 of 6 pages